Cinalukast
Cinalukast Uses, Dosage, Side Effects, Food Interaction and all others data.
Used in the treatment of asthma, cinalukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Cinalukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.
Trade Name | Cinalukast |
Generic | Cinalukast |
Cinalukast Other Names | Cinalukast |
Type | |
Formula | C23H28N2O3S |
Weight | Average: 412.545 Monoisotopic: 412.182063462 |
Groups | Experimental |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
For Protection against second- phase inflamation in exercise-induced bronchoconstriction and Asthma.
How Cinalukast works
Binds to the cysteinyl leukotriene receptor. The cysteinyl leukotrienes (LTC4, LTD4, LTE4) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. These eicosanoids bind to cysteinyl leukotriene receptors (CysLT) found in the human airway. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.
Innovators Monograph
You find simplified version here Cinalukast